Related Experiment Videos
Molecular structure and function of autoantigens in systemic sclerosis
1Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8031, USA.
International Reviews of Immunology
|January 1, 1995
Summary
Autoantibodies in systemic sclerosis (SSc) target nuclear proteins, aiding diagnosis. Their origin remains unknown but is likely linked to SSc
Area of Science:
- Immunology
- Rheumatology
- Cell Biology
Background:
- Autoantibodies targeting nuclear proteins are characteristic of systemic sclerosis (SSc).
- These autoantibodies are valuable diagnostic markers and research tools for SSc.
- The initiating events leading to autoantibody production in SSc are currently unknown.
Purpose of the Study:
- To explore the potential etiological link between autoantibody production and systemic sclerosis.
- To understand the significance of autoantibodies beyond their diagnostic utility in SSc.
Main Methods:
- Analysis of autoantibody specificities in patients with systemic sclerosis.
- Comparison of autoantibody profiles across different SSc clinical subtypes.
- Review of existing literature on autoantibody function and SSc pathogenesis.
Main Results:
- Autoantibodies in SSc primarily target nucleolar and RNA transcription complex proteins.
- Autoantibody profiles correlate with distinct clinical subsets of SSc (e.g., anti-kinetochore in limited cutaneous SSc, anti-topoisomerase I and anti-RNA polymerase in diffuse SSc).
- Unlike in Systemic Lupus Erythematosus (SLE), SSc autoantibodies are not typically associated with direct tissue damage or cellular invasion.
Conclusions:
- SSc-specific autoantibodies are not mere epiphenomena and likely relate to the disease's etiology.
- The distinct autoantibody profiles observed in different SSc syndromes suggest a connection to disease pathogenesis.
- Further research into the origins of these autoantibodies may provide insights into the underlying causes of systemic sclerosis.